PIK3CB and prostate carcinoma: Wei et al. discovered that prostate cancer cells undergoing ERS have increased exosomal PD-L1 levels and activated PI3K/AKT pathway, which promote M2 polarization of macrophages and establish an immunosuppressive environment (40).